Sierentz, France

Daniel Von Büren

This inventor holds 4 USPTO granted patents and 2 EPO patents. Top assignees: Roche Diagnostics International Ag, Roche Diabetes Care, Inc., Varian Medical Systems Particle Therapy Gmbh & Co Kg. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daniel Von Büren. Retrieved from https://idiyas.com/inventor/daniel-von-buren

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 75.0

 

Average Co-Inventor Count = 3.4

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Daniel von Büren - Innovative Inventor from Sierentz

Introduction: Daniel von Büren is a renowned inventor hailing from Sierentz, France, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Daniel von Büren holds several patents in the areas of renewable energy, sustainable agriculture, and advanced materials, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Daniel von Büren has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Daniel von Büren has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Daniel von Büren's passion for innovation and his relentless pursuit of excellence have solidified his position as a pioneering inventor in the global technological landscape.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…